Post-market real-world evidence
A myopia-control registry surface for lens manufacturers: axial-length velocity by treatment, the Stellest 1.0 → 2.0 generational step, subgroup performance across a diverse population, and registry governance.
The generational step
lower axial-length velocity, Stellest 2.0 vs 1.0
0.147 mm/yr → 0.084 mm/yr mean AL velocity (per-protocol, full-adherence subgroup).
Basis: per-protocol (full-adherence subgroup). Lower AL velocity = slower myopia progression.
Mean AL velocity
Head-to-head effectiveness
Current-generation arms on mean 24-month AL velocity. Lower bars = slower axial elongation; Stellest 2.0 leads the cohort.
Stellest 2.0 across ethnicities
AL velocity holds across all six groups — evidence the effect generalises across a diverse population, not just one anchor cohort.
Adherence & tolerability
Adherence distribution
- Full adherence73.1% · n=2,485
- Partial22.4% · n=761
- Poor4.5% · n=154
Mild photophobia
n=66
Discontinuation
n=61
Upgrade opportunity
On Stellest 1.0 with inadequate control (ORANGE/RED AL-velocity zone) at 24 months.
MODELLED — illustrative demo figure, not an observed commercial outcome.
Registry & governance
Australian sovereign hosting · de-identified by construction · audit-logged.